Analytical Data
-
基因名
EVI2A
- Application
-
别名
EVI2A; EVDA; EVI2; Protein EVI2A; EVI-2A
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P22794
-
表达区间
25-236aa
-
氨基酸序列
SPGTKANYTRLWANSTSSWDSVIQNKTGRNQNENINTNPITPEVDYKGNSTNMPETSHIVALTSKSEQELYIPSVVSNSPSTVQSIENTSKSHGEIFKKDVCAENNNNMAMLICLIIIAVLFLICTFLFLSTVVLANKVSSLRRSKQVGKRQPRSNGDFLASGLWPAESDTWKRTKQLTGPNLVMQSTGVLTATRERKDEEGTEKLTNKQIG
-
分子量
49.06 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EVI2A, or Ectopic Viral Integration site 2A, is a gene that has garnered increasing interest in molecular and cellular biology due to its implications in various physiological and pathological processes. Initially identified for its potential role in viral integration, recent studies have revealed that EVI2A is involved in important cellular mechanisms such as cell adhesion, migration, and signaling pathways, which are critical for developmental biology and cancer progression. Researchers are particularly interested in the expression and regulation of EVI2A, as alterations in its activity may contribute to the development of tumors and other diseases. Recombinant EVI2A proteins are being explored for their potential therapeutic applications, including their use in targeted therapies and as biomarkers for cancer diagnosis. The study of EVI2A also includes investigations into its interaction with other proteins and cellular components, enhancing our understanding of its biological functions. Overall, EVI2A represents a promising area of research that bridges virology, cellular biology, and cancer research, prompting further exploration into its role in health and disease.
